The menopausal hot flashes market is concentrated, and the degree of concentration will accelerate during the forecast period. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments while maintaining their positions in the slow-growing segments.
The menopausal hot flashes market report covers the following areas:
Menopausal Hot Flashes Market 2021-2025: Segmentation
- Distribution Channel
- Geography
- North America
- Europe
- Asia
- ROW
To learn more about the contribution of each segment of the market, Download a Free Sample
Menopausal Hot Flashes Market 2021-2025: Scope
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources.
Change in lifestyle, rise in disposable income, and increase of women in the workforce will offer immense growth opportunities. However, side effects, threat of substitutes, and high price and low availability will challenge the growth of the market participants.
Menopausal Hot Flashes Market 2021-2025: Vendor Analysis
We provide a detailed analysis of around 25 vendors operating in the menopausal hot flashes market, including AbbVie Inc., Amgen Inc., AstraZeneca Plc, Bayer AG, GlaxoSmithKline Plc, Merck KGaA, Mylan NV, Novartis AG, Novo Nordisk AS, and Pfizer Inc. Backed with competitive intelligence and benchmarking, our research report on the menopausal hot flashes market is designed to provide entry support, customer profile and M&As as well as go-to-market strategy support.
Subscribe to our "Lite Plan" billed annually at USD 3000 that enables you to download 3 reports/year and view 3 reports/month.
Menopausal Hot Flashes Market 2021-2025: Regional Analysis
Technavio's market research report includes detailed information on the competitive intelligence, marketing gaps, and regional opportunities for vendors to help organizations create efficient business plans. According to our research, 38% of the growth of the market will originate from North America during the forecast period. The US and Canada are the key countries for the menopausal hot flashes market in North America. Moreover, the growth of the market in this region will be faster than the growth of the market in Europe and ROW. The rise in awareness about menopausal symptoms and the benefits of using feminine hygiene products have resulted in an increase in demand for feminine hygiene products in North America. This will facilitate the growth of the menopausal hot flashes market growth in North America during the forecast period.
Menopausal Hot Flashes Market 2021-2025: Key Highlights
- CAGR of the market during the forecast period 2021-2025
- Detailed information on factors that will assist menopausal hot flashes market growth during the next five years
- Estimation of the menopausal hot flashes market size and its contribution to the parent market
- Predictions on upcoming trends and changes in consumer behavior
- The growth of the menopausal hot flashes market
- Analysis of the market's competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of menopausal hot flashes market vendors
Related Reports:
- Feminine Hygiene Wash Market: The feminine hygiene wash market has been segmented by distribution channel (offline and online) and geography (APAC, North America, Europe, South America, and MEA). Download Free Sample Report
- Menstrual Cups Market: The menstrual cups market has been segmented by product (reusable menstrual cups and disposable menstrual cups), distribution channel (retail and online), and geography (North America, Europe, Asia, and ROW). Download Free Sample Report
Menopausal Hot Flashes Market Scope |
Report Coverage |
Details |
Page number |
120 |
Base year |
2020 |
Forecast period |
2021-2025 |
Growth momentum & CAGR |
Accelerate at a CAGR of 3.82% |
Market growth 2021-2025 |
USD 2.19 billion |
Market structure |
Concentrated |
YoY growth (%) |
2.62 |
Regional analysis |
North America, Europe, Asia, and ROW |
Performing market contribution |
North America at 38% |
Key consumer countries |
US, UK, Germany, China, Canada, and Japan |
Competitive landscape |
Leading companies, competitive strategies, consumer engagement scope |
Companies profiled |
AbbVie Inc., Amgen Inc., AstraZeneca Plc, Bayer AG, GlaxoSmithKline Plc, Merck KGaA, Mylan NV, Novartis AG, Novo Nordisk AS, and Pfizer Inc. |
Market Dynamics |
Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for the forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
Related Links
http://www.technavio.com
Share this article